Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights

NEXT STORY
Portola Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
PREV STORY
Precipio Appoints New Board Member to Replace Departing Director
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioCryst Pharmaceuticals and Idera Pharmaceuticals File Preliminary Proxy Statement and Investor Presentation in Connection with Pending Merger

Provide Update on Key Benefits of Pending Merger and Comprehensive Evaluation of Strategic Opportunities Leading ...

author_avatar
NASDAQ Market News

Chembio Diagnostics, Inc. Announces Upsizing And Pricing Of Public Offering Of Common Stock

MEDFORD, N.Y., July 29, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018

FIT Biotech Oy Company release March 21, 2018 at 03:30 PM EET FIT Biotech ...

author_avatar
NASDAQ Market News